An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
National Institute of Environmental Health Sciences
Use this QR code to view the newest version of this document
Your Environment. Your Health.
Details for High Impact Journal
Superfund Research Program
Gastroenterology (impact factor: 22.682)
2023
Huang DQ, Wilson LA, Behling C, Kleiner D, Kowdley KV, Dasarathy S, Amangurbanova M, Terrault N, Diehl AM, Chalasani N, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, Loomba R, Allende D, Bellar A, Dasarathy J, Guy C, Kopping M, Piercy D, Suzuki A, Tawadrou N, Cruz M, Cummings OW, Garrison L, Gawrieh S, Samala N, Vuppalanchi R, Carpenter D, Cattoor T, Freebersyser J, Angkanaworakul P, Berihun A, Buysse A, Dorrian T, Gulati B, Liu K, Misic S, Sohal A, Vuong J, Ajmera VH, Madamba E, Middleton MS, Richards L, Singh S, Sirlin C, Gill R, Hameed B, Awe R, Olvera D, Yuan L, Yeh M, Albhaisi S, Asgharpour A, Boyett S, Contos MJ, Luketic VA, Schlosser J, Siddiqui MS, Adamo P, Belt P, Clark JM, DeSanto JM, Meinert J, Miriel L, Mitchell EP, Shade C, Smith J, Smith M, Sternberg A, Natta ML, Wagoner A, Woreta T, Yates KP. 2023. Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study. Gastroenterology 165(2):463-472. doi:10.1053/j.gastro.2023.04.025PMID:37127100
2021
Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wong VW, Wright E, Abdelmalek MF, Harrison SA, Loomba R, Mantzoros CS, Bugianesi E, Eckel RH, Kaplan LM, El-Serag HB, Cusi K. 2021. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology 161:1657-1669. doi:10.1053/j.gastro.2021.07.049PMID:34602251PMCID:PMC8819923
Loomba R, Ratziu V, Harrison SA. 2021. Expert panel review to compare FDA and EMA guidance on drug development and endpoints in nonalcoholic steatohepatitis. Gastroenterology 162(3):doi:10.1053/j.gastro.2021.10.051PMID:34822801
2020
Lang S, Demir M, Martin A, Jiang L, Zhang X, Duan Y, Wisplinghoff H, Gao B, Kasper P, Roderburg C, Tacke F, Steffen H, Goeser T, Abraldes JG, Tu XM, Loomba R, Starkel P, Pride D, Fouts DE, Schnabl B. 2020. Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology 159:1839-1852. doi:10.1053/j.gastro.2020.07.005PMID:32652145
Loomba R, Lim JK, Patton H, El-Serag HB. 2020. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 158:1822-1830. doi:10.1053/j.gastro.2019.12.053PMID:32006545PMCID:PMC8012107
Liang S, Ma H, Zhong Z, Dhar D, Liu X, Xu J, Koyama Y, Nishio T, Karin D, Karin G, Mccubbin R, Zhang C, Hu R, Yang G, Chen L, Ganguly S, Lan T, Karin M, Kisseleva T, Brenner DA. 2019. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Gastroenterology 156(4):1156-1172. doi:10.1053/j.gastro.2018.11.019PMID:30445007PMCID:PMC6409207
2018
Ajmera VH, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, Hooker J, Sy E, Behling C, Xu R, Middleton MS, Valasek MA, Faulkner C, Rizo E, Richards L, Sirlin CB, Loomba R. 2018. Magnetic Resonance Imaging Proton Density Fat Fraction Associates with Progression of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology 155(2):307-310. doi:10.1053/j.gastro.2018.04.014PMID:29660324PMCID:PMC6090543
2017
Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, Hooker J, Sy E, Savides MT, Valasek MA, Rizo E, Brenner DA, Sirlin CB, Loomba R. 2017. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152(3):598-607.e2. doi:10.1053/j.gastro.2016.10.026PMID:27911262PMCID:PMC5285304
Yang L, Inokuchi-Shimizu S, Roh Y, Song J, Loomba R, Park E, Seki E. 2013. Transforming growth factor-beta signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 144(5):1042-1054. doi:10.1053/j.gastro.2013.01.056PMID:23391818PMCID:PMC3752402
2012
Fujiwara R, Chen S, Karin M, Tukey RH. 2012. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kappa B leads to hyperbilirubinemia. Gastroenterology 142:109-U259. doi:10.1053/j.gastro.2011.09.045PMID:21983082PMCID:PMC3428231
Campbell-Thompson M, Reyher KK, Lauwers GY, Shiverick KT. 1998. Estrogens modulate gastro-duodenal hyerplasia and dysplasia induced by N-methyl-N'-nitrosoguanidine in rats. Gastroenterology 114(4):G2347.